Versigent (NYSE:VGNT) Raised to “Strong-Buy” at TD Cowen

Versigent (NYSE:VGNT) was upgraded by analysts at TD Cowen to a “strong-buy” rating in a research note issued on Tuesday, MarketBeat.com reports.

Several other research analysts also recently weighed in on VGNT. UBS Group initiated coverage on Versigent in a research note on Tuesday. They set a “buy” rating and a $43.00 price target for the company. Royal Bank Of Canada started coverage on Versigent in a research note on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 target price for the company. Fox Advisors upgraded Versigent to a “strong-buy” rating in a research note on Tuesday, April 7th. Finally, Wells Fargo & Company started coverage on Versigent in a research note on Monday, April 6th. They issued an “overweight” rating and a $35.00 target price for the company. Three equities research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $38.25.

Versigent Stock Performance

VGNT stock opened at $32.98 on Tuesday. Versigent has a fifty-two week low of $26.34 and a fifty-two week high of $34.99.